What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
His scientific interests lie mostly in Immunology, Lung, Chemokine, Pathology and Cancer research.
His work in Chronic lymphocytic leukemia, T lymphocyte, Immune system, Antigen and T cell are all subfields of Immunology research.
Within one scientific family, Gianpietro Semenzato focuses on topics pertaining to Pulmonary alveolus under T lymphocyte, and may sometimes address concerns connected to Cytotoxic T cell.
His work deals with themes such as Virus and Acquired immunodeficiency syndrome, which intersect with Lung.
His Pathology research focuses on Immunophenotyping and how it relates to CCL20, Interleukin 17, Lymph node, Peripheral blood and Monoclonal.
His study looks at the relationship between Cancer research and topics such as Hairy cell leukemia, which overlap with CD5, Lymphoproliferative disorders, CXCR5 and Mantle cell lymphoma.
His most cited work include:
- ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. (1030 citations)
- BRAF mutations in hairy-cell leukemia (749 citations)
- Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis (546 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Internal medicine, Cancer research, Chronic lymphocytic leukemia and Molecular biology.
His studies in Immunology integrate themes in fields like Cytotoxic T cell and Lung.
His study explores the link between Lung and topics such as Pathology that cross with problems in Immunophenotyping.
In his research, Rituximab is intimately related to Gastroenterology, which falls under the overarching field of Internal medicine.
His research in Cancer research intersects with topics in Cell growth, Kinase, Protein kinase A, Signal transduction and Leukemia.
His studies deal with areas such as Receptor, In vitro and Monoclonal antibody as well as Molecular biology.
He most often published in these fields:
- Immunology (43.94%)
- Internal medicine (26.26%)
- Cancer research (19.19%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (26.26%)
- Cancer research (19.19%)
- Oncology (6.82%)
In recent papers he was focusing on the following fields of study:
Gianpietro Semenzato mainly investigates Internal medicine, Cancer research, Oncology, Chronic lymphocytic leukemia and Multiple myeloma.
While the research belongs to areas of Internal medicine, Gianpietro Semenzato spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Survival rate.
His Cancer research research incorporates themes from Protein kinase A, Ibrutinib, Lymphoma, Leukemia and Bruton's tyrosine kinase.
His research integrates issues of Chemokine, Annexin A5, Scoring system and Chemotaxis in his study of Chronic lymphocytic leukemia.
His CD8 study results in a more complete grasp of Immunology.
His Immunology study integrates concerns from other disciplines, such as Neutropenia, Signal transduction and Clone.
Between 2016 and 2021, his most popular works were:
- STAT3 mutation impacts biological and clinical features of T-LGL leukemia (23 citations)
- Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis (18 citations)
- Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways (18 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Gianpietro Semenzato focuses on Internal medicine, Cancer research, Chronic lymphocytic leukemia, Immunology and Bruton's tyrosine kinase.
Gianpietro Semenzato works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Spleen, Major Molecular Response and Molecular Response.
His Cancer research research is multidisciplinary, incorporating elements of Plasma cell, Multiple myeloma and Cell growth.
His Chronic lymphocytic leukemia research incorporates elements of Neoplastic cell, Peripheral, Apoptosis, Receptor and Lymphocyte.
Immunology and Pathology are commonly linked in his work.
His Bruton's tyrosine kinase study combines topics in areas such as Ibrutinib, Chemokine, C-C chemokine receptor type 7, Syk and Endosome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
